New-onset Severe Headache After Covid-19 Vaccine

CompletedOBSERVATIONAL
Enrollment

63

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

October 1, 2023

Study Completion Date

December 31, 2023

Conditions
HeadacheMigraineCOVID-19
Interventions
OTHER

observation

observation

Trial Locations (10)

Unknown

Medi3, Ålesund

Hodepineklinikkken Bergen, Bergen

Anub Mathew Thomas, Drammen

Helsa Fonna Trust, Haugesund

Møre og Romsdal Hospital Trust, Molde

Kristina Devik, Namsos

Hodeverket, Sandnes

Sandvika Nevrosenter, Sandvika

St Olav University Hospital, Trondheim

0424

Oslo University Hospital, Oslo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

St. Olavs Hospital

OTHER

collaborator

University Hospital, Akershus

OTHER

collaborator

Vestre Viken Hospital Trust

OTHER

collaborator

Hodepineklinikken Bergen

UNKNOWN

collaborator

Molde Hospital

OTHER

collaborator

Namsos Hospital

OTHER

collaborator

Medi3

UNKNOWN

collaborator

Oslo Hodepinesenter

UNKNOWN

collaborator

Sandvika Nevrosenter

UNKNOWN

lead

Oslo University Hospital

OTHER

NCT05235776 - New-onset Severe Headache After Covid-19 Vaccine | Biotech Hunter | Biotech Hunter